Massimo Andreoni

11.3k total citations
315 papers, 5.3k citations indexed

About

Massimo Andreoni is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Massimo Andreoni has authored 315 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 185 papers in Infectious Diseases, 135 papers in Epidemiology and 112 papers in Virology. Recurrent topics in Massimo Andreoni's work include HIV Research and Treatment (111 papers), HIV/AIDS drug development and treatment (100 papers) and HIV/AIDS Research and Interventions (67 papers). Massimo Andreoni is often cited by papers focused on HIV Research and Treatment (111 papers), HIV/AIDS drug development and treatment (100 papers) and HIV/AIDS Research and Interventions (67 papers). Massimo Andreoni collaborates with scholars based in Italy, United States and United Kingdom. Massimo Andreoni's co-authors include Loredana Sarmati, Emanuele Nicastri, Stefano Vella, Lucia Palmisano, Barbara Ensoli, Giovanni Rezza, Carlo Federico Perno, Sergio Bernardini, Gabriella d’Ettorre and Saverio Giuseppe Parisi and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Massimo Andreoni

298 papers receiving 5.2k citations

Peers

Countries citing papers authored by Massimo Andreoni

Since Specialization

Citations

This map shows the geographic impact of Massimo Andreoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Andreoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Andreoni more than expected).

Fields of papers citing papers by Massimo Andreoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Andreoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Andreoni. The network helps show where Massimo Andreoni may publish in the future.

Co-authorship network of co-authors of Massimo Andreoni

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Andreoni. A scholar is included among the top collaborators of Massimo Andreoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Andreoni. Massimo Andreoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bridging the gap: advancing health equity and eliminating HBV and HCV among marginalized populations 2025 ·The Lancet Regional Health - Europe ·Loreta A. Kondili, Maria Giovanna Quaranta, Massimo Andreoni	0
2	Bacteriophage-enhanced doxycycline activity against Escherichia coli in chronic bacterial prostatitis 2025 ·International Journal of Antimicrobial Agents ·Novella Cesta, Adelaide Fusco, (unknown), (unknown), (unknown), Cartesio D’Agostini, Marco Iannetta, Massimo Andreoni, Arianna Tavanti, Loredana Sarmati, Mariagrazia Di Luca	0
3	RSV vaccination as the optimal prevention strategy for older adults 2024 ·Infezioni in Medicina ·Massimo Andreoni, Paolo Bonanni, (unknown), Stefania Maggi, Roberta Siliquini, Andrea Ungar	2
4	Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals 2023 ·Journal of Clinical Virology ·Daniele Armenia, Roberta Gagliardini, Claudia Alteri, Valentina Svicher, Valeria Cento, Vanni Borghi, Alessandra Vergori, Stefania Cicalini, Federica Forbici, Lavinia Fabeni, Ada Bertoli, (unknown), William Gennari, Vincenzo Malagnino, Massimo Andreoni, Cristina Mussini, Andrea Antinori, Carlo Federico Perno, Maria Mercedes Santoro, Francesca Ceccherini‐Silberstein	4
5	The future for COVID-19 vaccines: public health assessment and perspectives based on scientific evidence 2023 ·Infezioni in Medicina ·Massimo Andreoni, Paolo Bonanni, Andrea Cossarizza, Giovanni Gabutti, Francesco Gesualdo, Andrea Grignolio, Giancarlo Icardi, Pier Luigi Lopalco, Francesco Vitale	2
6	Real-life Data on Cefiderocol Efficacy and Safety to Treat Multidrug-Resistant Acinetobacter baumannii Infections 2023 ·Open Forum Infectious Diseases ·Laura Campogiani, (unknown), (unknown), (unknown), Luigi Coppola, Mirko Compagno, (unknown), (unknown), Vincenzo Malagnino, Elisabetta Teti, Cartesio D’Agostini, (unknown), (unknown), (unknown), Massimo Andreoni, Marco Iannetta, Loredana Sarmati	3
7	From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy 2023 ·The Journal of Infectious Diseases ·Loreta A. Kondili, Lucia Craxì, Felice Nava, Sergio Babudieri, Roberta D’Ambrosio, Andrea Marcellusi, Francesco Saverio Mennini, (unknown), Pierluigi Russo, Pier Paolo Olimpieri, Massimo Andreoni, Alessio Aghemo	7
8	Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae subsp. pneumoniae Isolates in a Tertiary Italian Hospital: Identification of a New Mutation of the Carbapenemase Type 3 (KPC-3) Gene Conferring Ceftazidime/Avibactam Resistance 2021 ·Microorganisms ·Carla Fontana, Marco Favaro, Laura Campogiani, Vincenzo Malagnino, Silvia Minelli, (unknown), (unknown), Massimo Andreoni, Loredana Sarmati	14
9	Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 2021 ·PLoS Pathogens ·Martina Severa, Roberta A. Diotti, Marilena P. Etna, Fabiana Rizzo, Stefano Fiore, (unknown), Marco Iannetta, Alessandro Sinigaglia, A Lodi, Nicasio Mancini, Elena Criscuolo, Massimo Clementi, Massimo Andreoni, Stefano Balducci, Luisa Barzon, Paola Stefanelli, Nicola Clementi, Eliana M. Coccia	59
10	Appraisal of a Simple and Effective RT-qPCR Assay for Evaluating the Reverse Transcriptase Activity in Blood Samples from HIV-1 Patients 2020 ·Pathogens ·Beatrice Macchi, (unknown), Francesca Marino‐Merlo, Antonella Minutolo, (unknown), Emanuela Balestrieri, Carlotta Cerva, Loredana Sarmati, Massimo Andreoni, Sandro Grelli, Antonio Mastino	2
11	Rapid COVID-19 Screening Based on Self-Reported Symptoms: Psychometric Assessment and Validation of the EPICOVID19 Short Diagnostic Scale 2020 ·Journal of Medical Internet Research ·Luca Bastiani, Loredana Fortunato, (unknown), Fabrizio Bianchi, Fulvio Adorni, Federica Prinelli, Andrea Giacomelli, Gabriele Pagani, Stefania Maggi, Caterina Trevisan, Marianna Noale, Nithiya Jesuthasan, Aleksandra Šojić, Carla Pettenati, Massimo Andreoni, Raffaele Antonelli Incalzi, Massimo Galli, Sabrina Molinaro	28
12	COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells 2020 ·Genes ·Andrea Latini, Emanuele Agolini, Antonio Novelli, Paola Borgiani, (unknown), Paolo Gravina, Andrea Smarrazzo, Mario Dauri, Massimo Andreoni, Paola Rogliani, Sergio Bernardini, Manuela Helmer‐Citterich, Michela Biancolella, Giuseppe Novelli	84
13	Missed Opportunities of Flu Vaccination in Italian Target Categories: Insights from the Online EPICOVID 19 Survey 2020 ·Vaccines ·Andrea Giacomelli, Massimo Galli, Stefania Maggi, Gabriele Pagani, Raffaele Antonelli Incalzi, Claudio Pedone, Mauro Di Bari, Marianna Noale, Caterina Trevisan, Fabrizio Bianchi, Marcello Tavio, Massimo Andreoni, Claudio Maria Mastroianni, Aleksandra Šojić, Federica Prinelli, Fulvio Adorni	7
14	Tuberculosis-Related Hospitalizations in a Low-Incidence Country: A Retrospective Analysis in Two Italian Infectious Diseases Wards 2019 ·International Journal of Environmental Research and Public Health ·Laura Campogiani, Mirko Compagno, Luigi Coppola, Vincenzo Malagnino, Gaetano Maffongelli, (unknown), Daniela Francisci, Franco Baldelli, Carla Fontana, Sandro Grelli, Massimo Andreoni, Giovanni Sotgiu, Laura Saderi, Loredana Sarmati	2
15	Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success 2019 ·Journal of Clinical Virology ·Claudia Alteri, Rossana Scutari, (unknown), Gaetano Maffongelli, (unknown), Francesca Falasca, Salvatore Martini, Ada Bertoli, Ombretta Turriziani, Loredana Sarmati, Nicola Coppola, Massimo Andreoni, Maria Mercedes Santoro, Carlo Federico Perno, Francesca Ceccherini‐Silberstein, Valentina Svicher	22
16	Position Paper. Per un programma di eliminazione della Epatite C nella popolazione a rischio dei consumatori di sostanze e dei detenuti 2018 ·Felice Nava, A. Albertí, Massimo Andreoni, Sergio Babudieri, Giorgio Barbarini, (unknown), Claudio Leonardi, Alfio Lucchini	2
17	HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications. 2012 ·PubMed ·Massimo Andreoni, Andrea Giacometti, Ivana Maida, Paola Meraviglia, Diego Ripamonti, Loredana Sarmati	42
18	Fib4 is an independent predictor of serious liver disease among HIV-infected patients with or without HBV/HCV co-infection in the Icona foundation study 2010 ·UCL Discovery (University College London) ·(unknown), Mattia Prosperi, Sergio Lo Caputo, Cristina Gervasoni, C Mussini, Massimo Andreoni, Anna Maria Gori, (unknown), A. D’Arminio Monforte	4
19	Antibiotic Susceptibility of Lactobacilli Isolated from the Cervix of Healthy Women 2002 ·Microbial Ecology in Health and Disease ·Gian Piero Testore, C. Sarrecchia, (unknown), (unknown), E Valli, (unknown), Massimo Andreoni	7
20	Human herpesvirus-8 in lymphomatous and nonlymphomatous body cavity effusions developing in Kaposi's sarcoma and multicentric Castleman's disease 1999 ·Annals of Diagnostic Pathology ·Valeria Ascoli, Maria Caterina Sirianni, Ivano Mezzaroma, Claudio Maria Mastroianni, Vincenzo Vullo, Massimo Andreoni, Pasquale Narciso, (unknown), Francesco Nardi, Alessandra Pistilli, Francesco Lo‐Coco	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact